Vaccines Working Party documents

VWP Conclusions from the Workshop on Co-administration of Vaccines held on 31 Jan-1 Feb 2006

Reference Number: EMEA/CHMP/VWP/14684/2007

European Medicines Agency pandemic-influenza crisis management plan for the evaluation and maintenance of pandemic-influenza vaccines and antivirals

Adopted Reference Number: EMEA/214301/2006 Legal effective date: 01/09/2006

European Union influenza pandemic process map

Draft guideline on dossier structure and content of marketing authorisation applications for influenza vaccines with avian strains with a pandemic potential for use outside of the core dossier context

Draft: consultation closed Reference Number: EMEA/CHMP/VWP/263499/2006

Core summary of product characteristics for pandemic-influenza vaccines - Superseded

Adopted Reference Number: EMEA/CHMP/VWP/193031/2004 Rev- 1 Legal effective date: 01/08/2009

Guideline on procedural aspects regarding a CHMP scientific opinion in the context of cooperation with the World Health Organization for the evaluation of medicinal products intended exclusively for markets outside the C...

Adopted Reference Number: EMEA/CHMP/5579/04 Rev.1 Legal effective date: 01/05/2005

Note for guidance on the clinical evaluation of vaccines

Reference Number: CHMP/VWP/164653/2005

Guideline on adjuvants in vaccines for human use (see also explanatory note)

Adopted Reference Number: EMEA/CHMP/VEG/134716/2004 Legal effective date: 31/07/2005

Concept paper on the development of a Committee for Human Medicinal Products (CHMP) revised guideline on clinical evaluation of new vaccines

Reference Number: CHMP/VEG/1820/04

Guideline on submission of marketing authorisation applications for pandemic influenza vaccines through the centralised procedure - Superseded

Adopted Reference Number: EMEA/CPMP/VEG/4986/03 Legal effective date: 30/04/2004

Draft guideline on dossier structure and content for pandemic influenza vaccine marketing authorisation application (revision) - Superseded

Draft: consultation closed Reference Number: EMEA/CPMP/VEG/4717/03- Rev.1

Draft guideline on adjuvants in vaccines

Reference Number: EMEA/CPMP/VEG/17/03/2004v 5/Consultation Legal effective date: 25/03/2004

Note for guidance on the development of vaccinia virus based vaccines against smallpox

Adopted Reference Number: CPMP/1100/02 Legal effective date: 01/07/2002